Abstract
The progress that has been made against esophageal carcinoma is limited. Many relevant issues remain. Herein the author discusses his outlook for the treatment of this disease, which has a steadily rising incidence.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenocarcinoma / therapy
-
Biomedical Research* / trends
-
Carcinoma, Squamous Cell / therapy
-
Esophageal Neoplasms / therapy*
-
Forecasting
-
Humans